Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
2007 1
2010 1
2011 2
2012 4
2013 3
2014 1
2015 4
2016 4
2017 2
2018 1
2019 3
2020 10
2021 7
2022 5
2023 9
2024 11
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Antigen dominance hierarchies shape TCF1+ progenitor CD8 T cell phenotypes in tumors.
Burger ML, Cruz AM, Crossland GE, Gaglia G, Ritch CC, Blatt SE, Bhutkar A, Canner D, Kienka T, Tavana SZ, Barandiaran AL, Garmilla A, Schenkel JM, Hillman M, de Los Rios Kobara I, Li A, Jaeger AM, Hwang WL, Westcott PMK, Manos MP, Holovatska MM, Hodi FS, Regev A, Santagata S, Jacks T. Burger ML, et al. Among authors: tavana sz. Cell. 2021 Sep 16;184(19):4996-5014.e26. doi: 10.1016/j.cell.2021.08.020. Cell. 2021. PMID: 34534464 Free PMC article.
Lymphocyte networks are dynamic cellular communities in the immunoregulatory landscape of lung adenocarcinoma.
Gaglia G, Burger ML, Ritch CC, Rammos D, Dai Y, Crossland GE, Tavana SZ, Warchol S, Jaeger AM, Naranjo S, Coy S, Nirmal AJ, Krueger R, Lin JR, Pfister H, Sorger PK, Jacks T, Santagata S. Gaglia G, et al. Among authors: tavana sz. Cancer Cell. 2023 May 8;41(5):871-886.e10. doi: 10.1016/j.ccell.2023.03.015. Epub 2023 Apr 13. Cancer Cell. 2023. PMID: 37059105 Free PMC article.
Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial.
Ghanei M, Ghalebaghi B, Sami R, Torabizadeh M, Mirsadraee M, Amra B, Tavakol M, Raji H, Fallahpour M, Kiani A, Abedini A, Jabbari Azad F, Mahdaviani SA, Attaran D, Samet M, Tavana S, Haddadzadeh Shoushtari M, Nazari J, AghaeiMeybodi F, Fazlollahi MR, Ghasemi R, Sabzvari A, Kafi H, Idani E. Ghanei M, et al. Among authors: tavana s. Front Immunol. 2024 Jul 29;15:1425906. doi: 10.3389/fimmu.2024.1425906. eCollection 2024. Front Immunol. 2024. PMID: 39136011 Free PMC article. Clinical Trial.
A Comprehensive Study on the Prognostic Value and Clinicopathological Significance of Different Immune Checkpoints in Patients With Colorectal Cancer: A Systematic Review and Meta-Analysis.
Azizi M, Mokhtari Z, Tavana S, Bemani P, Heidari Z, Ghazavi R, Rezaei M. Azizi M, et al. Among authors: tavana s. Curr Ther Res Clin Exp. 2024 Sep 12;101:100760. doi: 10.1016/j.curtheres.2024.100760. eCollection 2024. Curr Ther Res Clin Exp. 2024. PMID: 39434898 Free PMC article. Review.
Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran.
Ansarin K, Attaran D, Jamaati H, Masjedi MR, Abtahi H, Alavi A, Aliyali M, Asnaashari AM, Farid-Hosseini R, Ghayumi SM, Ghobadi H, Ghotb A, Halvani A, Nemati A, Rahimi Rad MH, Rahimian M, Sami R, Sohrabpour H, Tavana S, Torabi-Nami M, Vahedi P. Ansarin K, et al. Among authors: tavana s. Tanaffos. 2015;14(2):73-94. Tanaffos. 2015. PMID: 26528362 Free PMC article. Review.
66 results